Tyra Biosciences has announced the establishment of Upper Tract Urothelial Cancer (UTUC) Awareness Day, in collaboration with the Bladder Cancer Advocacy Network (BCAN).
UTUC is a rare cancer affecting the lining of the kidneys and ureters, with a high prevalence of activating FGFR3 alterations. Standard treatment approaches frequently involve endoscopic tumor ablation or, in more advanced cases, surgical removal of the kidney and ureter (nephroureterectomy), which can lead to long-term health complications.
There remains a significant unmet need for an effective, kidney-sparing treatment option. Currently, there is no well-established systemic standard of care for patients with UTUC.
Through this collaboration, Tyra and BCAN aim to increase awareness of the disease, amplify the patient experience, and highlight the importance of continued research and innovation for people living with UTUC.
